Why the study?
Does abrupt withdrawal of amantadine precipitate neuroleptic-induced catatonia in patients on neuroleptic therapy?
Does abrupt withdrawal of amantadine precipitate neuroleptic-induced catatonia in patients on neuroleptic therapy?
Abrupt withdrawal of amantadine during neuroleptic therapy can precipitate neuroleptic-induced catatonia, suggesting a shared dopaminergic mechanism with neuroleptic malignant syndrome.
Answers are grounded in this paper and cite their sources.
May warrant gradual amantadine taper with neuroleptics; hypothesis-generating for shared dopaminergic mechanisms with NMS.
Catatonic reactions to high-potency neuroleptic drugs have been described in the literature. Our patient developed neuroleptic-induced catatonia (NIC) after abrupt withdrawal of amantadine, a dopaminergic agent that has been implicated in neuroleptic malignant syndrome (NMS) on its discontinuation. This case report adds support to the hypothesis that NIC and NMS are 2 syndromes on a continuum of dopamine blockade, each of which may be treated with or uncovered by amantadine therapy.
No takes yet. Share an insight, caveat, or question.
Brown et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: